RPRX

Royalty Pharma
RPRX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$14.68B
EV
$24.30B
Shares Outstanding
421.37M
Beta
0.47

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$41.52
P/E 2025E
7.88x
P/Revenue 2025E
4.76x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Royalty Pharma plc

gainify
RPRX

Royalty Pharma plc

RPRX

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical t...

Sector

Healthcare

Industry

Biotechnology

CEO

Legorreta, Pablo

Employees

IPO Date

2020-06-16

Headquarters

110 East 59th Street, New York, New York, 10022, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.